Gilmartin Geoffrey S. Insider Trades

Insider Trading History

Track insider trading activity for Gilmartin Geoffrey S.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Proteostasis Therapeutics
Proteostasis Therapeutics PTI
Chief Medical Officer
Holding Value $156k 140,100 shares
Last Trade
Mar 02, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$220k 140,100 shares
$1.57
$1.11
Yumanity Therapeutics
Yumanity Therapeutics YMTX
Chief Medical Officer
Holding Value $265k 140,100 shares
Last Trade
Mar 02, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$220k 140,100 shares
$1.57
$1.89
Yumanity Therapeutics
Yumanity Therapeutics YMTX
Chief Development Officer
Holding Value $101k 53,450 shares
Last Trade
Mar 01, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$230k 53,450 shares
$4.30
$1.89
Proteostasis Therapeutics
Proteostasis Therapeutics PTI
Chief Medical Officer
Holding Value $59.3k 53,450 shares
Last Trade
Mar 01, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$230k 53,450 shares
$4.30
$1.11
Proteostasis Therapeutics
Proteostasis Therapeutics PTI
Chief Medical Officer
Holding Value $16.6k 14,911 shares
Last Trade
Feb 04, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$27.5k 9,189 shares
$2.99
$1.11
Yumanity Therapeutics
Yumanity Therapeutics YMTX
Chief Development Officer
Holding Value $28.2k 14,911 shares
Last Trade
Feb 04, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$27.5k 9,189 shares
$2.99
$1.89
Yumanity Therapeutics
Yumanity Therapeutics YMTX
Chief Development Officer
Holding Value $45.5k 24,100 shares
Last Trade
Feb 01, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$72.3k 24,100 shares
$3.00
$1.89
Yumanity Therapeutics
Yumanity Therapeutics YMTX
Chief Development Officer
Holding Value $0 0 shares
Last Trade
Feb 01, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$72.3k 24,100 shares
$3.00
$1.89
Proteostasis Therapeutics
Proteostasis Therapeutics PTI
Chief Medical Officer
Holding Value $26.8k 24,100 shares
Last Trade
Feb 01, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$72.3k 24,100 shares
$3.00
$1.11
Proteostasis Therapeutics
Proteostasis Therapeutics PTI
Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Feb 01, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$72.3k 24,100 shares
$3.00
$1.11
Proteostasis Therapeutics
Proteostasis Therapeutics PTI
Chief Medical Officer
Holding Value $33.2k 29,900 shares
Last Trade
Mar 01, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$93k 29,900 shares
$3.11
$1.11
Yumanity Therapeutics
Yumanity Therapeutics YMTX
Chief Development Officer
Holding Value $56.5k 29,900 shares
Last Trade
Mar 01, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$93k 29,900 shares
$3.11
$1.89
Yumanity Therapeutics
Yumanity Therapeutics YMTX
Chief Development Officer
Holding Value $45.5k 24,100 shares
Last Trade
Feb 01, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$77.1k 24,100 shares
$3.20
$1.89
Proteostasis Therapeutics
Proteostasis Therapeutics PTI
Chief Medical Officer
Holding Value $26.8k 24,100 shares
Last Trade
Feb 01, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$77.1k 24,100 shares
$3.20
$1.11
Proteostasis Therapeutics
Proteostasis Therapeutics PTI
Chief Development Officer
Holding Value $26.8k 24,100 shares
Last Trade
Feb 01, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$77.1k 24,100 shares
$3.20
$1.11

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up